Although checkpoint blockades have become widely used, the immunological impact in cancer patients, especially those with oral cavity squamous cell carcinoma (OCSCC), has not been well studied. | Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma